SARS-CoV-2 infections after Pfizer-BioNTech BNT162b2 vaccination in routinely screened workforce


What The Study Did: This study describes an association between the Pfizer-BioNTech BNT162b2 vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Authors: Li Tang, Ph.D., of the St. Jude Children’s Research Hospital in Memphis, Tennessee, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.